Many flavonoids have so far been isolated as main secondary metabolites in plant species of the genus Eriosema (Fabaceae), which contains approximately 160 species. A total of 52 flavonoids including isoflavones, dihydroflavonols, flavonols, flavanones, dihydrochalcones, isoflavanone and their pyrano or glucoside derivatives were isolated and characterized from the five species of this genus investigated to date. Total synthesis and semi-synthesis (acetylation, methylation, hydrogenation, and cyclization) of some isolated flavonoids were reported. Due to several significant pharmacological properties (antimicrobial, cytotoxicity, anti-mycobacterial, antioxidant, antiviral, erectile-dysfunction, vasodilatory and hypoglycemic) of the isolated flavonoids and derivatives, more scientists should be interested in investigating Eriosema species. The present review is the first to document all flavonoids that have been reported from the genus Eriosema to date together with their synthetic and semi-synthetic derivatives, and their pharmacological properties. Dihydrochalcones, which are precursors of other classes of flavonoids, are very rare in natural sources and their isolation from Eriosema species may explain the large number of flavonoids found in this genus. It appears that isoflavone could be a marker for species in this genus. The 83 flavonoids (1-83) documented include 52 isolates, 31 semisynthetic and 3 totally synthetic derivatives. Data were obtained from Google scholar, Pubmed, Scifinder, Sciencedirect, and Scopus. With 52 different flavonoids isolated from only 5 of the approximately 160 species it shows the remarkable chemical diversity of this genus. This compilation of the biological activities and chemical composition may renew the interest of pharmacologists and phytochemists in this genus.
The genus Eriosema, a member of the Fabaceae family, contains about 160 species, mostly distributed in tropical regions of Africa, that are used in traditional medicine to treat various diseases [1] [2] [3] [4] [5] [6] . Flavonoids appear to be the main secondary metabolites reported in the genus [6, 7] . This review documents all the flavonoids that have been reported from Eriosema species to date, together with their synthetic and semi-synthetic derivatives, and their various pharmacological properties (antimicrobial, cytotoxicity, antimycobacterial, antioxidant, antiviral, erectile-dysfunction, vasodilatory and hypoglycemic). Data were obtained from Google scholar, Sciencedirect, Scopus, Pubmed, and Scifinder. In total, information for 83 flavonoids (1-83) is documented. This includes 31 semi-synthetic and 3 totally synthetic derivatives, as well as 52 different flavonoids isolated from 5 Eriosema species. These results indicate the phytochemical and pharmacological wealth of flavonoids present in Eriosema species and should encourage the investigation of more species.
The botany and distribution of the genus
The genus Eriosema (DC) Rchb1828 consists mainly of herbs or shrubs. The species are found mainly in Africa. About 109 species occur only in subtropical Africa and 34 in southern Africa and subtropical Africa [8] . They grow in different environments in tropical and subtropical forest margins to grassland, rocky and swampy areas. There are about 40 species that occur from Mexico to northern Argentina and two in south-east Asia to Australia [9] .
Chemistry
Isolated flavonoids: Flavonoids have been reported from 1995 to date as major constituents identified in Eriosema species [6, 7] ( Figure 1 , Table 1 ). Eriosemaones A (1), B (2), C (3) and D (4), and flemichin D (5) , isolated from the dichloromethane extract of the roots of E. tuberosum, were the first report of flavonoids from the genus [7] . Further investigation was carried out on the same species to afford lupinifolin (6) [10] . Isoflavonoid glucosides and isoflavonoids, including 5-O-methylgenistein-7-O--Dapiofuranosyl-(1→6)-O--D-glucopyranoside (7) , genistein 7-O--D-apiofuranosyl-(1→6)-O--D-glucopyranoside (8) , eriosemaside C (9), 5-O-methylgenistein-7-O--D-glucopyranoside (10), genistin (11) , sphaerobioside (12) , genistein (13) , and 5-O-methylgenistein (14) , were reported from the n-butanol-soluble fraction of a methanol extract of the roots of E. tuberosum [11, 12] . Seven pyrano-isoflavones, kraussianones (15) (16) (17) (18) (19) (20) (21) , were reported from the extract of the roots of E. kraussianum N. E. Br. [1, 2] . Two dihydrochalcones, erioschalcones A (22) and B (23) were isolated for the first time from the dichloromethane/methanol (1:1, v/v) extract of the whole plant of E. glomerata, together with one flavonol, quercetin (24) and one isoflavone, isoluteolin (25) [3] . Khonklonginols A-H (26-33), six flavonols and two flavanones were reported as novel derivatives, along with five known flavonoids, lupinifolinol (34), dehydrolupinifolinol (35), eriosemaone A (1), flemichin D (5), and lupinifolin (6) from the nhexane and dichloromethane extracts of the roots of E. chinense [13] . Investigation of the ethanol extract of the twigs of E. robustum gave two novel flavonols, robusflavones A (36) and B (37), together 
Classes Compounds Plant species and parts Pharmacological Activities Flavanone
Eriosemaone A (1) Eriosema tuberosum (Roots) [7] E. chinense (Roots) [13] Antifungal [7] , Cytotoxicity [13] , Antimycobacterial [13] Flavanone Eriosemaone B (2) E. tuberosum (Roots) [ [7] E. chinense (Roots) [13] Antifungal [7] , Cytotoxicity [13] , Antimycobacterial [13] , Antioxidant [6] , Antimicrobial [6] Flavanone Lupinifolin (6) E. tuberosum (Roots) [10] E. chinense (Roots) [13] Antifungal [10] , Cytotoxicity [13] , Antimycobacterial [13] Isoflavone glucoside [6] Antioxidant [6] , Antimicrobial [6] Pyranoflavonol 3,5,2ˈ,4ˈ-Tetrahydroxy-6",6"-dimethylpyrano(2",3":7,6)-8-(3"',3"'-dimethylallyl)flavone (42) E. chinense (Roots) [6] Antioxidant [6] , Antimicrobial [6] Dihydroflavonol (2R,3R,2"'R)-3,5,2"'-Trihydroxy-4-methoxy-6",6"dimethylpyrano(2",3":7,6)-8-(3"'-methyl-but-3"'enyl)flavanone (43) [6] Anticancer [17] , Antimicrobial [24] * Also reported as total synthetic derivatives, -: not reported with a known flavanone, 6-prenylpinocembrin (38) [4, 5] . (11), astragalin (51) and cajanol (52) were further reported from the n-hexane, dichloromethane, and methanol extracts of the roots of E. chinense [6] .
The isolated flavonoids reported from this genus, are mainly isoflavones (21 compounds), followed by dihydroflavonols (11), flavonols (9), flavanones (8), dihydrochalcones (2) and one isoflavanone. Dihydrochalcones, which are precursors of other classes of flavonoids, are very rare from natural sources. Their isolation from the genus Eriosema may explain the large number of flavonoids found in this genus.
Synthetic and semi-synthetic derivatives:
The semi-synthesis and total synthesis investigations reported were carried out to facilitate separation, to obtain enough samples for bioassays, to improve the pharmacological activity and/or to evaluate the structure-activity relationship (SAR) of some isolated compounds. Lupinifolinol (34) [6, 13] Antimicrobial [6] -: not reported Semi-synthesis using acetylation, methylation, hydrogenation, and cyclization reactions were reported for some flavonoids isolated from Eriosema genus (Figure 2 ). Acetylation and methylation were carried out on eriosemaone B (2) A column chromatography fraction of the extract of E. tuberosum was methylated and on purification gave 2',6',2,4-tetramethoxy-5'γ,γ-dimethylallyl-6",6"-dimethylpyrano(3",2":3',4')-chalcone (60), 5,3',5'-trimethoxy-8-γ,γ-dimethylallyl-6",6"-dimethylpyrano(2",3":6,7)flavanone (61), and 5,2',4'-trimethoxy-8-γ,γdimethylallyl-6",6"-dimethylpyrano(2",3":6,7) flavanone (62) [7] . Cyclization of kraussianone 2 (15), isolated from E. kraussianum N. E. Br., afforded 5,2-dihydroxy-[(6″,6″-dimethylpyrano(2″,3″:4,5)] [(6″,6″-dimethyl-4″,5″-dehydropy-rano(2″,3″:7,6)]-isoflavone (63) [1, 2] .
Nine semi-synthetic derivatives were obtained by methylation, cyclization and acetylation reactions of erioschalcones A (22) and B (23) isolated from E. glomerata [3, 14] . These included 1- The total synthesis of pyrano-isoflavone kraussianone 1 (15) , as well as isoflavones eriosemaone D (4) and genistein (13) , were achieved using the Suzuki-Miyaura reaction followed by the regioselective formation of the dimethylpyran scaffolds to the phloroglucinol (ring A) and resorcinol (ring B) moieties [16] .
Chemotaxonomic significance of flavonoids from Eriosema genus
Among secondary metabolites found in Eriosema species, flavonoids are widely represented. A large number of isoflavones has been isolated, followed by dihydroflavonols, flavonols, Flavonoids from Eriosema: chemistry and pharmacology Natural Product Communications Vol. 10 (7) 2015 1329 flavanones, dihydrochalcones and isoflavanones. Isoflavones were reported from E. tuberosum [7, 11, 12] , E. kraussianum [1, 2] , E. glomerata [3] , and E. chinense [6] . The occurrence of isoflavones could be considered as a marker for this genus and may have a chemotaxonomic significance for Eriosema species.
Pharmacological activities
Various pharmacological activities have been investigated for flavonoids of the genus Eriosema and their derivatives. These include antimicrobial, cytotoxic, erectile-dysfunction, antioxidant, vasodilatory, hypoglycemic, and L-NAME pre-eclamptic activities. Prominent results are highlighted below while all the pharmacological activities are documented in Tables 1 and 2 .
Antimicrobial activity and cytotoxicity
Compounds 1-6 and 9, and their derivatives (53-62), inhibited the growth of Cladosporium cucumerinum and Candida albicans using thin layer chromatography (TLC) bioassays [7, 10, 12] . Compounds 1, 5 and 6 had significant anti-mycobacterial activity against Mycobacterium tuberculosis H37Ra (MIC 12.5 µg/mL in all cases) and cytotoxicity to small-cell lung (NCI-H187) and oral epidermal carcinoma (KB) human cell lines were reported with IC 50 values of 5.8 and 6.0 µg/mL, 3.3 and 2.1 µg/mL, and 2.4 and 6.5 µg/mL, respectively [13] . Further antimicrobial activity was reported for compound 5, which significantly inhibited the growth of Bacillus cereus, Enterococcus faecalis, Listeria monocytogenes, Staphylococcus aureus, S. aureus (MRSA), S. epidermidis, Streptococcus agalactiae, and S. pyrogenes, with MICs of 4.7 µg/mL in all cases [6] . The antimicrobial activity, expressed as radius of the zone of inhibition (RZI), of erioschalcones A (22) and B (23), compounds 24 and 25 were reported at a concentration of 1 µg/µL [3] . Erioschalcone B (23) had significant antifungal activity against Microbotryum violaceum (RZI of 13 mm), whereas erioschalcone A (22) had some activity against the Gram-negative bacterium Escherichia coli (RZI of 10 mm) [3] . Antimycobacterial activity and cytotoxicity were also reported for khonklonginols A (26), B (27), F (31) and H (33), lupinifolinol (34), and dehydrolupinifolinol (35) [13] . Dehydrolupinifolinol (35) was active against M. tuberculosis H37Ra (MIC 12.5 µg/mL), while lupinifolinol (34) had an IC 50 of 1.73 µg/mL on oral epidermal carcinoma (KB) human cell line [13] . Cytotoxicity towards smallcell lung (NCI-H187), and human oral epidermal carcinoma (KB), and Vero cell lines were also reported for compounds 26 (IC 50 3.0, 3.1, 7.9 µg/mL), 27 (IC 50 4.3, 3.8, 6.9 µg/mL), 31 (IC 50 2.4, 6.7, 7.0 µg/mL), and 33 (IC 50 3.3, 5.4, 6.4 µg/mL), respectively [13] . These results were reported with IC 50 values of 0.37, and 0.44 µg/mL, and 0.12 and 0.042 µg/mL for the reference standards, doxorubicin and isoniazid, on KB and NCI-H187 cell lines, respectively [13] . [6] . The antimicrobial and cytotoxicity of robusflavones A (36) and B (37), and 6-prenylpinocembrin (38) were reported. They all had low antimicrobial activity: compound 36 against C. albicans and P. aeruginosa (MICs 63 µg/mL), compound 37 against C. albicans, Aspergillus fumigatus (MICs 65 µg/mL) and P. aeruginosa (MIC 63 µg/mL), and compound 38 against C. albicans (MIC 65 µg/mL), S. aureus (MIC 31.3 µg/mL), P. aeruginosa (MIC 63 µg/mL), E. faecalis and E. coli (MICs 63 µg/mL) [5] . The LC 50 s of compounds 36, 37, and 38 on monkey Vero cells were 13.20, 30.42, and 21.87 µg/mL, respectively [5] . Cajanol (52) inhibited the growth of MCF-7 human breast cancer cells in a time and dose-dependent manner and had IC 50 values of 54.0 µM after 72 h treatment, 58.3 µM after 48 h, and 83.4 µM after 24 h [17] . Compound 52 also arrested the cell cycle in the G2/M phase and induced apoptosis via a ROSmediated mitochondria-dependent pathway [17] .
Three semi-synthetic derivatives (75, 78 and 80) were tested for antimicrobial activity. Compound 75 had good activity against a Gram-negative bacterium Pseudomonas aeruginosa (MIC 4.7 µg/mL), while compound 78 was significantly active against S. pyrogenes (MIC 9.4 µg/mL) [6] . Compound 80 also had significant activity against B. cereus, and S. pyrogenes (MICs 4.7 µg/mL) and against E. faecalis, S. aureus (MRSA), and S. agalactiae (MICs 9.4 µg/mL) [6] .
Erectile-dysfunction, antioxidant and antiviral activities
Erectile-dysfunction activity was reported on seven pyranoisoflavones, kraussianones 1 -7 (15 -21), isolated from E. kraussianum. At a concentration of 78 ng/mL kraussianone 1 (15) had a percentage contraction of cavernosal smooth muscle (85%) comparable with that of Viagra (100%), while the contraction due to kraussianone 2 (16) was 65% relaxation of smooth muscle [1] .
Antioxidant activity was determined for compounds 5 (IC 50 0.54 mM), 26 (IC 50 7.92 mM), 34 (IC 50 1.77 mM), 39 (IC 50 0.62 mM), 41 (IC 50 0.25 mM), 42 (IC 50 0.035 mM), 44 (IC 50 2.55 mM), 47 (IC 50 3.67 mM), 48 (IC 50 0.028 mM), 50 (IC 50 0.65 mM) and 52 (IC 50 0.68 mM) using the free radical 2,2-diphenyl-1-picryhydrazyl (DPPH) with butylated hydroxytoluene (BHT) as reference standard (IC 50 0.039 nM) [6] . The antioxidant activity of robusflavones A (36) and B (37), and 6-prenylpinocembrin (38) was reported; compounds 36 and 37 had significant radical scavenging activity (IC 50 1.13 and 1.19 mg/mL) compared with the standard, L-ascorbic acid (IC 50 1.00 mg/mL) [4] . Compound 10 showed antiviral activity [18] .
Other activities
Insecticidal activity of sphaerobioside (12) , and genistein (13) was reported using a fumigation method against four stored-product pests (Callosobruchus chinense, Sitophilus oryzae, Rhyzopertha dominica, and Tribolium castaneum). Compounds 12 and 13 had LC 50 values of 0.21, 0.17 µg/mL, 0.18, 0.28 µg/mL, 0.27, 0.28 µg/mL, and 0.20, 0.18 µg/mL against C. chinense, S. oryzae, R. dominica, and T. castaneum, respectively [19] . Hundred percent mortality after 24 h at the concentration of 1 µg/mL on all the test insects was also obtained with compounds 12 and 13 [19] .
Conclusion
A comprehensive review of flavonoids from the genus Eriosema is presented from 1995 to date. Some of the reported compounds underwent chemical modifications to afford derivatives, while others were produced by total chemical synthesis. Pharmacological properties of most of the isolated compounds and derivatives are summarized. Chemotaxonomic significance of flavonoids from this genus was documented and isoflavone was suggested as a marker for Eriosema species. From this review, it is obvious that good collaboration between biologists and phytochemists is needed. Knowing that researchers are still interested in investigating
